Author/Authors :
Summaria, Francesco Department of Cardiology - San Eugenio Hospital, Rome, Italy , Sgueglia, Gregory A. Department of Cardiology - San Eugenio Hospital, Rome, Italy , D’Errico, Fabrizio Department of Cardiology - San Eugenio Hospital, Rome, Italy , De Santis, Antonella De Department of Cardiology - San Eugenio Hospital, Rome, Italy , Piccioni, Fabiana Department of Cardiology - San Eugenio Hospital, Rome, Italy , Gioffre, Gaetano Department of Cardiology - San Eugenio Hospital, Rome, Italy , Gaspardone, Achille Department of Cardiology - San Eugenio Hospital, Rome, Italy
Abstract :
We present the complex case of a high-risk patient with nonvalvular atrial fibrillation, who experienced a non-ST elevation
myocardial infarction complicated by left ventricular (LV) thrombi and underwent percutaneous coronary intervention with
drug-eluting stent implantation. *e patient was initially treated with short-term triple therapy including aspirin, clopidogrel, and
rivaroxaban 15 mg/die. Following aspirin dropping one month after discharge, the patient continued on dual therapy with
clopidogrel and rivaroxaban, and a clinical and imaging follow-up at 6 and 12 months confirmed the LV thrombi resolution, with
no thromboembolic episodes and a good safety profile.
Keywords :
Safety and Efficacy , Rivaroxaban , Acute Myocardial Infarction Complicated , Left Ventricular Thrombi , Atrial Fibrillation
